Translational Molecular Nuclear Cardiology

James T. Thackeray, Frank M. Bengel

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Increased rollout and availability of preclinical imaging provides a foundation for development of novel molecular nuclear imaging agents. The current armamentarium of radiotracers available for nuclear cardiology allows for the interrogation of critical molecular processes involved in a myriad of cardiovascular disorders, including altered metabolism, ventricular remodeling, sympathetic neuronal activation, and systemic inflammation. Effective translational molecular imaging requires coordination of clinical need with tracer development and molecular biology, leading to the identification of ideal translational imaging compounds.

Original languageEnglish (US)
Pages (from-to)187-198
Number of pages12
JournalCardiology clinics
Issue number1
StatePublished - Feb 2016


  • Cardiovascular disease
  • PET
  • Translational imaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Translational Molecular Nuclear Cardiology'. Together they form a unique fingerprint.

Cite this